参考文献/References:
[1] 李航,方文捷,熊林,等.侵袭性真菌感染早期诊断技术的研究进展[J].菌物学报,2019,38(2):151-158.
LI Hang,FANG Wenjie,XIONG Lin,et al.Research progress in early diagnosis of invasive fungal infections[J].Mycosystema,2019,38(2):151-158.
[2] BOAN P,GARDAM D.Epidemiology and antifungal susceptibility patternsof candidemia from a tertiary centre in Western Australia[J].Journal of Chemotherapy(Florence,Italy),2019,31(1):1-4.
[3] 何小羊,任秋霞,杨英.2008～2017年我国深部真菌病原谱及流行特征国内文献系统分析[J].中国真菌学杂志,2018,13(4):229-234.
HE Xiaoyang,REN Qiuxia,YANG Ying.The study of the pathogenic spectrum and epidemiologic features of invasive fungal infection in China during 2008-2017[J].Chinese Journal of Mycology,2018,13(4):229-234.
[4] 丁艳苓,沈宁,周庆涛,等.非免疫缺陷宿主念珠菌血流感染[J].北京大学学报(医学版),2018,50(6):1063-1069.
DING Yanling,SHEN Ning,ZHOU Qingtao,et al.Clinical analysis of Candida immunocompetent patients[J].Journal of Peking University(Health Sciencis),2018,50(6):1063-1069.
[5] ULU KILIC A,ALP E,CEVAHIR F,et al.Epidemiology and cost implicationsof candidemia,a 6-year analysis from a developing country[J].Mycoses,2017,60(3):198-203.
[6] 章强强.我国真菌感染的实验室检查现状[J].诊断学理论与实践,2016,15(1):1-4.
ZHANG Qiangqiang.The status of laboratory examination of fungal infection in China[J].Journal of Diagnostics Concepts and Practice,2016,15(1):1-4.
[7] 余进.真菌检验技术进展[J].临床检验杂志,2017,35(10):721-724.
YU Jin.Progress in fungal testing technology[J].Chinese Journalof Clinical Laboratory Science,2017,35(10):721-724.
[8] IDELEVICH E A,SEIFERT H,SUNDQVIST M,et al.Microbiological diagnosticsof bloodstream infections in Europe-An ESGBIES survey[J].Clinical Microbiology and Infection:DOI:https://doi.org/10.1016/j.cmi.2019.03.024.
[9] 宋星澎,郑锐.念珠菌血流感染的诊治进展[J].医学综述,2019,25(4):758-762.
SONG Xingpeng,ZHENG Rui.Progress in diagnosis and treatment of Candida bloodstream infection[J].Medical Recapitulate,2019,25(4):758-762.
[10] YANG Shuangshuang,XU Haofeng,SUN Jide.Shi-fting trends and age distribution of ESKAPEEc resistance in bloodstream infection,Southwest China,2012-2017[J].Antimicronial Resistance and Infection Control,2019,8:61.
[11] DE PAUW B E,WALSH T J,DONNELLY J P,et al.Revised definitions of invasive fungal disease from the European Organization for Research and Treatment ofCancer/Invasive Fungal Infections Cooperative Group and the National Instituteof Allergy and Infectious Diseases Mycoses Study Group(EORTC/MSG)Consensus Group[J].Clin Infect Dis,2008,46(12):1813-1821.
[12] KUMAR J,SINGH A,SETH R,et al.Galactomannan antigen test for early diagnosis of invasive aspergillus infection in pediatric febrile neutropenia[J].Indian Pediatr,2018,55(3):257-258.
[13] 吴真,徐晓刚.深部真菌病的实验诊断进展[J].中国感染与化疗杂志.2014,14(1):82-85.
WU Zhen,XU Xiaogang.current status and evolvement of laboratory diagnosis foe deep fungal diseases[J].Chinese Journal of Infection and Chemotherapy.2014,14(1):82-85.
[14] 焦二莉,李跃宇,马文慧.侵袭性真菌感染的3种免疫学检测方法的应用研究[J].卫生检验,2016,13(20):117-119.
JIAO Erli,LI Yueyu,MA Wenhui.Application research on three immunologictest methods of invasive infections with fungi[J].China Health Industry,2016,13(20):117-119.
[15] ZHANG Shuzhen, WANG Sibu, WAN Zhe,et al.The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluidgalactomannan assay[J].Biomed Res Int,2015,2015:943691.
[16] 曹林,沈记录.隐球菌检验方法的应用[J].中国感染与化疗杂志,2018,18(1):113-117.
CAO Lin,SHEN Jilu.Application of laboratory te-sts for identifying Cryptococcus[J].Chinese Journal of Infection and Chemotherapy,2018,18(1):113-117.
[17] PERFECT J R,BICANIC T.Cryptococcosis diagnosis and treatment:what dowe know now[J].Fungal Genet & Biol,2015(78):49-54.
[18] 任增花,徐凌.侵袭性肺曲霉菌病诊断方法的研究进展[J].中国临床医学,2018,25(6):1009-1015.
REN Zenghua,XU Ling.Research progress in diagnostic methods of invasivepulmonary aspergillosis[J].Chinese Journal of Clinical Medicine,2018,25(6):1009-1015.
[19] ARVANITIS M,ZIAKAS P D,ZACHARIOUDA-KIS I M,et al.PCR in diagnosis of invasive aspergillosis:a meta-analysis of diagnostic performance[J].J Clin Microbiol,2014,52(10):3731-3742.
[20] ZHAO Yanan,PADERU P,RAILKAR R A,et al.Blood aspergillus RNA is a promising alternative biomarker for invasive aspergillosis[J].Med Mycol,2016,54(8):801-807.
[21] 王玉连,吴建华.中药抗真菌作用研究进展[J].世界临床药物,2018,39(9):638-642.
WANG Yulian,WU Jianhua.Advances on antifungal treatment through Chinese herbal medicine[J].World Clinical Drugs,2018,39(9):638-642.
相似文献/References:
[1]翟华丽,刘艳丽,丁丽丽,等.2012～2014年医院血培养主要病原菌分布及耐药性分析[J].现代检验医学杂志,2015,30(03):104.[doi:10.3969/j.issn.1671-7414.2015.03.030]
ZHAI Hua-li,LIU Yan-li,DING Li-li,et al.Distribution and Drug Resistance of Main Pathogens
Isolated from Blood Culture from 2012 to 2014[J].Journal of Modern Laboratory Medicine,2015,30(04):104.[doi:10.3969/j.issn.1671-7414.2015.03.030]
[2]黄莲芬,周珍文,钟华敏,等.广州地区儿童患者脑脊液分离病原菌构成及耐药特征[J].现代检验医学杂志,2018,33(01):81.[doi:10.3969/j.issn.1671-7414.2018.01.001]
HUANG Lian-fen,ZHOU Zhen-wen,ZHONG Hua-min,et al.Composition and Drug Resistance of Pathogenic Isolates
from CSF Culture of Pediatric Patients in Guangzhou[J].Journal of Modern Laboratory Medicine,2018,33(04):81.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[3]谷钰峰,李 昱,张晓录,等.基于MALDI-TOFMS与FCM联合应用对临床血流感染病原体鉴定和药敏试验新方法的建立和应用[J].现代检验医学杂志,2018,33(04):2.[doi:10.3969/j.issn.1671-7414.2018.04.006]
GU Yu-feng,LI Yu,ZHANG Xiao-lu,et al.A New Method Aimed to Quickly Identify Pathogen and Drug
Susceptibility Test Based on MALDI-TOF MS Combined with FCM[J].Journal of Modern Laboratory Medicine,2018,33(04):2.[doi:10.3969/j.issn.1671-7414.2018.04.006]
[4]高正琴.中国北京地区犬真菌监测与药敏分析[J].现代检验医学杂志,2018,33(04):25.[doi:10.3969/j.issn.1671-7414.2018.04.007]
GAO Zheng-qin.Monitoring and Antifungal Susceptibility of Canine Fungi
in Beijing Region of China[J].Journal of Modern Laboratory Medicine,2018,33(04):25.[doi:10.3969/j.issn.1671-7414.2018.04.007]
[5]武爱荣.孕晚期阴道及肛周拭子不同方法检测B族链球菌和真菌的效果评价及耐药分析[J].现代检验医学杂志,2018,33(03):108.[doi:10.3969/j.issn.1671-7414.2018.03.027]
WU Ai-rong.Effect Evaluation and Drug Resistance Analysis
of B Streptococcus and Fungus in Swab of Vaginal
and Perianal Detected with Different Methods in Late Pregnancy[J].Journal of Modern Laboratory Medicine,2018,33(04):108.[doi:10.3969/j.issn.1671-7414.2018.03.027]
[6]张 戈,张小江,胡继红,等.国产全自动血培养系统及配套血培养瓶性能评估[J].现代检验医学杂志,2018,33(06):132.[doi:10.3969/j.issn.1671-7414.2018.06.034]
ZHANG Ge,ZHANG Xiao-jiang,HU Ji-hong,et al.Performance Evaluation of Domestic LABSTAR120 Automated Blood Culture System and Its Blood Culture Bottles[J].Journal of Modern Laboratory Medicine,2018,33(04):132.[doi:10.3969/j.issn.1671-7414.2018.06.034]
[7]王 晶a,马 娟a,范 云a,等.2015～2017年陕西省人民医院临床血流感染病原菌的分布及耐药性分析[J].现代检验医学杂志,2019,34(04):87.[doi:10.3969/j.issn.1671-7414.2019.04.021]
WANG Jinga,MA Juana,FAN Yuna,et al.Distribution and Drug Resistance of Pathogenic Bacteria of Blood
Culture in Shaanxi Provincial People's Hospital form 2015 to 2017[J].Journal of Modern Laboratory Medicine,2019,34(04):87.[doi:10.3969/j.issn.1671-7414.2019.04.021]
[8]关佳灏,赵 海,王 翠,等.2018年陕西省人民医院全自动血培养仪及配套鉴定系统分离病原菌的实验室特征及耐药分析[J].现代检验医学杂志,2019,34(06):113.[doi:10.3969 ／ j.issn.1671-7414.2019.06.028]
GUAN Jia-hao,ZHAO Hai,WANG Cui,et al.Laboratory Characteristics and Drug Resistance Analysis of Pathogenic
Bacteria Isolated by Automatic Blood Culture Instrument and Matching
Idetification System in Shaanxi Provincial People’s Hospital in 2018[J].Journal of Modern Laboratory Medicine,2019,34(04):113.[doi:10.3969 ／ j.issn.1671-7414.2019.06.028]
[9]任继欣,郭彦言.外周血HBP，IL-6，CD64 指数，PCT，CRP 和SAA 水平检测在血流感染诊断中的应用价值研究[J].现代检验医学杂志,2020,35(02):56.[doi:10.3969/j.issn.1671-7414.2020.02.017]
REN Ji-xin,GUO Yan-yan.Application Value of Peripheral Blood HBP, Interleukin-6, CD64 Index, PCT,CRP ，SAA Level Detection in Blood Stream Infection Diagnosis[J].Journal of Modern Laboratory Medicine,2020,35(04):56.[doi:10.3969/j.issn.1671-7414.2020.02.017]
[10]何家花,余成强,李步荣.血流感染病原学分析及与相关炎性因子的应用价值研究[J].现代检验医学杂志,2020,35(04):139.[doi:10.3969/j.issn.1671-7414.2020.04.035]
HE Jia-hua,YU Cheng-qiang,LI Bu-rong.Pathogen Analysis of Bloodstream Infection and Study on the Application Value of Related Inflammatory Factors[J].Journal of Modern Laboratory Medicine,2020,35(04):139.[doi:10.3969/j.issn.1671-7414.2020.04.035]